By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
Despite positive fundamentals like 14% revenue growth and a $5.3B backlog, panelists agree that Ameresco's (AMRC) thin net margins and high capital intensity pose significant risks, particularly around cash conversion cycles and financing costs.
Risk: Extended cash conversion cycles and elevated financing costs on a $5.3B backlog could erode earnings and cash flow.
Opportunity: Improving cash conversion cycles and securing cheaper capital could unlock significant upside.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Francis V. Wisneski Jr., a member of the Board of Directors at Ameresco (NYSE:AMRC), reported the sale of 10,000 shares of Class A Common Stock for approximately $303,000 on May 19, 2026, following an option exercise as disclosed in the SEC Form 4 filing.
| Metric | Value | |---|---| | Shares sold (direct) | 10,000 | | Transaction value | ~$303K | | Post-transaction shares (direct) | 25,232 | | Post-transaction value (direct ownership) | ~$730K |
Transaction value based on SEC Form 4 weighted average reported price ($30.29); post-transaction value based on May 19, 2026 market close.
| Metric | Value | |---|---| | Revenue (TTM) | $1.98 billion | | Net income (TTM) | $31.48 million | | Employees | 1,500 |
Ameresco is a leading clean technology integrator specializing in comprehensive energy efficiency and renewable energy solutions. With an established presence across the United States, Canada, and international markets, the company leverages deep engineering expertise to deliver customized projects that lower energy costs and carbon footprint for institutional and commercial clients.
Ameresco's integrated business model, combining project development with long-term asset operation, positions it to benefit from the growing demand for sustainable infrastructure and resilient energy systems.
The May 19 sale of Ameresco stock by long-time Director Francis V. Wisneski Jr., who joined the Board in 2011, occurred when shares had nearly doubled above their 52-week low of $15.52 reached in 2025. He sold another 5,000 shares on May 29 after the stock price continued to rise.
While these sales do not engender investor confidence in Ameresco stock’s future potential, Wisneski was granted restricted stock units in June, bringing his directly-held stock to over 35,000 shares as of June 4, indicating that he maintains a sizable equity stake.
Ameresco's share price is up in 2026 because of rising energy consumption thanks to the advent of artificial intelligence. Construction of data centers to house AI systems is growing, increasing the urgent need to modernize electrical grids.
This helped Ameresco grow first-quarter revenue 14% year over year to $401.5 million, while its total backlog of customer projects increased 8% year over year to $5.3 billion in the face of record business development activity.
Before you buy stock in Ameresco, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Ameresco wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $397,890! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,196,664!
Now, it’s worth noting Stock Advisor’s total average return is 902% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 30, 2026. *
Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Ameresco's thin net margins are a greater risk to shareholder value than the routine insider selling activity highlighted in the filing."
The market is fixated on the 'AI infrastructure' narrative, but Ameresco's (AMRC) fundamentals tell a more nuanced story. While a 14% revenue growth is respectable, a TTM net income of $31.48 million on $1.98 billion in revenue highlights razor-thin net margins of ~1.6%. The director's sale is essentially a non-event—a routine exercise-and-sell that is common for long-tenured board members managing personal liquidity. The real risk here isn't insider selling; it's the company's ability to scale profitability in a capital-intensive sector where project delays or interest rate volatility can quickly erode those slim margins. Investors are paying a premium for the 'data center energy' tailwind, but the bottom-line conversion remains underwhelming.
If Ameresco successfully converts its $5.3 billion backlog into high-margin long-term service contracts, the current low net margin will expand significantly, making the stock look cheap at current levels.
"Wisneski's sale is mechanical option exercise, not conviction; the RSU grant and $5.3B backlog are the actual signals, and both point to sustainable demand from AI infrastructure buildout."
Wisneski's sale is being framed as bearish, but the article undermines its own thesis. He exercised options and sold immediately—classic tax-efficient liquidity, not conviction selling. More telling: he received RSUs in June, restoring his stake to 35k+ shares. The real signal is AMRC's fundamentals: 14% Q1 revenue growth, $5.3B backlog (+8% YoY), and AI-driven data center demand creating genuine tailwinds. At $30.29, the stock trades ~15.2x TTM earnings ($31.48M net income on $1.98B revenue = 1.59% margin, which is thin but improving). The article's dismissal feels reflexive—director selling always reads as negative—but the RSU grant and backlog growth suggest management confidence.
AMRC's 1.59% net margin is dangerously thin for a capital-intensive business; if project execution stumbles or competition intensifies, that backlog converts to losses, not profits. The AI data center boom is real but cyclical—if capex spending slows, AMRC's growth evaporates.
"Option-exercise sales by long-tenured directors rarely move the needle when new equity grants restore ownership within weeks."
Wisneski's May 19 sale of 10k AMRC shares at $30.29 was an immediate post-exercise liquidation of vested options, cutting direct holdings 28% to 25k while leaving 20k options intact. The article notes he later received RSUs lifting direct ownership above 35k by June 4, so the trade looks like routine liquidity rather than a vote of no confidence. Still, the timing after the stock doubled from its 2025 low coincides with AI-driven backlog growth to $5.3B and 14% Q1 revenue gains, raising the question of whether early profit-taking by a 2011 board member precedes any re-rating risk if data-center demand normalizes.
The largest single sale in recent filings plus the 4.7% discount to the May 23 close could still reflect private doubts about sustaining 8% backlog growth once AI capex peaks, even after the RSU top-up.
"Insider liquidity trades are not a reliable signal of future performance; the stock's risk/return hinges on backlog execution and funding cycles, not on one director's sale."
Insider action here reads as a liquidity event more than a surgery on conviction: Wisneski exercised 10k options and sold ~$303k, trimming direct holding to 25,232 shares while retaining 20k options and RSUs. That preserves upside but signals he may need cash, not necessarily downgrading belief in Ameresco’s long-term backlog. The positives in the piece—backlog $5.3B, Q1 revenue up 14% to $401.5M—are real, but note Ameresco’s TTM revenue (~$1.98B) and net income ($31.5M) imply slim margins and high capital intensity. The AI-narrative is probabilistic; government-funded projects and interest-rate sensitivity remain material risk if execution or funding slows.
Even with a liquidity read, a big insider sale can undermine confidence, especially when funds may be needed for other uses; and the remaining 20k options create potential future selling pressure if the stock rallies further.
"Ameresco's high-capital intensity and interest-rate sensitivity make its $5.3 billion backlog a potential cash-flow liability rather than a pure growth engine."
Gemini and Claude focus on margins, but you are all missing the working capital trap. Ameresco’s business model requires massive upfront cash to fund energy projects before government or utility payments materialize. With interest rates elevated, the cost of financing that $5.3 billion backlog is a silent margin killer. It’s not just about 'execution'—it’s about cash conversion cycles. If they can't optimize their balance sheet, that backlog is a liability, not an asset.
"Working capital risk is real, but the backlog's pricing structure—not just interest rates—determines whether it's a margin killer or already baked into contract terms."
Gemini's working capital point is sharp and underexplored. But it cuts both ways: elevated rates do compress margins on project financing, yet AMRC's $5.3B backlog likely includes long-term service contracts with fixed pricing—meaning they've already locked in margins before rate spikes. The real trap is whether backlog conversion timelines stretch, tying up cash longer. Nobody's asked: what's the average project-to-cash cycle? That matters more than the rate environment alone.
"Fixed pricing fails to protect against ongoing financing costs that can erase thin margins on delayed projects."
Claude's point on fixed pricing in backlog contracts overlooks that interest expense on project financing hits continuously regardless of locked revenue. At 1.6% net margins, any extension in cash conversion cycles from the $5.3B backlog directly erodes earnings before those contracts even convert. The real unaddressed risk is balance sheet drag, not just execution timelines.
"AMRC's cash-conversion risk is the real lever that could suppress profitability; backlog alone won't fix margins if working capital is strained."
Gemini is right to flag working capital, but the discussion still skirts the core math: a $5.3B backlog financed upfront with high rates means cash conversion risk is the real Achilles' heel, not just margins. If cash cycles extend or financing costs creep, even fixed-price backlog may underwrite negative cash flow. Until AMRC can demonstrate a materially shorter cash cycle or cheaper capital, the upside is capped.
Despite positive fundamentals like 14% revenue growth and a $5.3B backlog, panelists agree that Ameresco's (AMRC) thin net margins and high capital intensity pose significant risks, particularly around cash conversion cycles and financing costs.
Improving cash conversion cycles and securing cheaper capital could unlock significant upside.
Extended cash conversion cycles and elevated financing costs on a $5.3B backlog could erode earnings and cash flow.